Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Cancel
Submit
Search the CDC
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Start of Search Controls
Search Form Controls
Search The CDC
Cancel
Submit
Search The CDC
Tuberculosis (TB)
Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page:
About CDC.gov
.
Tuberculosis
Basic TB Facts
How TB Spreads
Latent TB Infection and TB Disease
Signs & Symptoms
TB Risk Factors
Exposure to TB
TB Prevention
Vaccines
TB & HIV Coinfection
TB Terms
Personal Stories
Deo
Esteban and Danielle
Kenni
Liliana
Mabruka
Martha
Natalie
Rick and Francene
Rosalie and Faith
Santos
Sarah
Tri
Testing & Diagnosis
Who Should be Tested
Testing for TB Infection
Testing in BCG-Vaccinated Persons
Testing Health Care Workers
Testing During Pregnancy
Diagnosing latent TB infection and TB disease
Treatment
Deciding When to Treat Latent TB Infection
Treatment Regimens for Latent TB Infection (LTBI)
Treatment for TB Disease
Adverse Events
TB Treatment of Persons Living with HIV
TB Treatment and Pregnancy
TB Treatment for Children
Drug-Resistant TB
Research
TB Epidemiologic Studies Consortium
Research Projects
Publications
TB Trials Consortium
Study Descriptions
Background
Behavioral & Social Science Research
Infection Control
TB in Specific Populations
African-American Community
Stop TB in the African-American Community Summit
Background
Slideset
Children
Correctional Facilities
Homelessness
International Travelers
Pregnancy
Health Disparities
Laboratory Information
Model Performance Evaluation Program (MPEP)
Drug Susceptibility Testing
The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TB
Background
General Considerations
Research Needs
Molecular Drug Susceptibility Tests (DSTs)
Communication Plan for New Recommendations
General Recommendations of the Expert Panel
Recommendations to ACET, CDC, DTBE
Rapid Molecular Testing to Detect Drug-Resistant TB in the US
Executive Summary
Introduction
Background on Tests for Molecular Detection of DR
General Considerations and Principles for a Molecular DR Testing Service
�
Possible Scenarios and Scope of Testing for a Molecular DR Testing Service
Research Needs
General Recommendations of the Expert Panel
Communication Plan for the Report
Recommendations
References
Panel Members and CDC Participants
Appendix 1
Appendix 2
Appendix 3
Interim Laboratory Biosafety Guidance for XDR
Mycobacterium
tuberculosis strains
Data & Statistics
Trends in Tuberculosis, 2015
TB Incidence in the United States
Reported TB in the US, Surveillance Report
Tuberculosis in the United States, 2015 (Slide Set)
Archived Surveillance Reports and Slide Sets
Professional Resources & Tools
Tools for Healthcare Providers
Resources for TB Programs
Publications & Products
Patient and Public Materials
Fact Sheets
General
Data & Statistics
Drug-Resistant TB
Infection Control & Prevention
TB in Specific Populations
Treatment
Testing & Diagnosis
Vaccines & Immunizations
Guidelines
Contact Investigations
Control & Elimination
Drug-Resistant TB
Genotyping
Infection Control & Prevention
Laboratory
TB & HIV
TB in Specific Populations
Testing & Diagnosis
Treatment
Vaccines & Immunizations
Guidelines by Date
Guides & Toolkits
TB eDOT Toolkit
Core Curriculum
Self-Study Modules
Report of Verified Case of Tuberculosis (RVCT)
Forging Partnerships to Eliminate TB
Understanding the TB Cohort Review Process
Latent Tuberculosis Infection: A Guide for Primary Health Care Providers
Effective TB Interviewing for Contact Investigation
Mantoux Tuberculin Skin Testing Products
Ethnographic Guides
TB Contact Investigation Interviewing Skills Course
Newsletters
TB Notes, No. 4, 2017
TB Notes, No. 3, 2017
TB Notes, No. 2, 2017
TB Notes, No. 1, 2017
TB Notes, No. 5, 2016
TB Notes, No. 4, 2016
TB Notes, No. 3, 2016
TB Notes, No. 2, 2016
TB Notes, No. 1, 2016
Pamphlets, Brochures, Booklets
Questions and Answers
Patient Education Series
Tuberculosis – Get the Facts
Tuberculosis – The Connection between TB and HIV
12-Dose Regimen for Latent TB Infection-Patient Education Brochure
Posters
Mantoux Tuberculin Skin Test Wall Chart
World TB Day
Think TB
Stop TB
Reports & Articles
Morbidity and Mortality Weekly Reports (MMWRs)
DTBE Authored Journal Articles
Tuberculosis Laboratory Aggregate Reports
Slide Sets
Self-Study Modules on Tuberculosis, 1-5 Slide Sets
The Tuberculosis (TB) in Correctional Settings
Facilitator Guide
Introduction to TB Genotyping
Core Curriculum
Epidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2014
Prevention and Control of Tuberculosis in Correctional and Detention Facilities
Guidelines for Preventing the Transmission of M. TB in Health care Settings
Investigation of Contacts of Persons with Infectious TB
Epidemiology of Pediatric Tuberculosis in the United States
Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection
Electronic Tools & Resources
Web-Based Courses & Webinars
TB 101 for Health Care Workers
TB 101 CE Credits
Interactive Core Curriculum
Program Evaluation
Content Syndication
Infographics
Social Media Graphics
Events
World TB Day
Resources
U.S. TB Champions
Activities
History
Links
State TB Control Offices
TB Control Programs
About Us
Mission Statement and Activities
DTBE Strategic Plan
National TB Program Objectives
Organization Chart
Advisory Groups
Federal TB Task Force
Morbidity and Mortality Weekly Reports (MMWRs)
Recommend on Facebook
Tweet
Share
Compartir
TB in Specific Populations
Foreign-Born
High-Risk Settings
Homeless
International
Occupational Groups
Travel
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
RIS file
Page last reviewed:
September 1, 2012
Page last updated:
September 1, 2012
Content source:
Division of Tuberculosis Elimination
Top